Manufacturers have reduced GLP-1 drug prices to $299–$349/month for cash paying consumers, a 70%+ drop from 2021 prices.
While cash paying consumers see 70% reductions, employer (insurance) paid costs though PBMs remain essentially unchanged.
The power of cash is evident and proves competition can work in healthcare.
Cash pay can be added to any plan at any time so why wait? Everyone wins. Plan sponsor wins, providers win and plan members win.
